ArcticZymes Technologies ASA (OSTO:BIOTECO) Interest Expense : kr0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is ArcticZymes Technologies ASA Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ArcticZymes Technologies ASA's interest expense for the three months ended in Dec. 2024 was kr 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ArcticZymes Technologies ASA's Operating Income for the three months ended in Dec. 2024 was kr 0.5 Mil. ArcticZymes Technologies ASA's Interest Expense for the three months ended in Dec. 2024 was kr 0.0 Mil. GuruFocus does not calculate ArcticZymes Technologies ASA's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ArcticZymes Technologies ASA Interest Expense Historical Data

The historical data trend for ArcticZymes Technologies ASA's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Interest Expense Chart

ArcticZymes Technologies ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.63

-0.69

-0.68

-0.50

-0.35

ArcticZymes Technologies ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

ArcticZymes Technologies ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

ArcticZymes Technologies ASA (OSTO:BIOTECO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ArcticZymes Technologies ASA's Interest Expense for the three months ended in Dec. 2024 was kr0.0 Mil. Its Operating Income for the three months ended in Dec. 2024 was kr0.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was kr4.4 Mil.

ArcticZymes Technologies ASA's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

GuruFocus does not calculate ArcticZymes Technologies ASA's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. ArcticZymes Technologies ASA has enough cash to cover all of its debt. Its financial situation is stable.

ArcticZymes Technologies ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (OSTO:BIOTECO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

AZT:Norway 0DRV:UK

Address

Sykehusveien 23, Tromso, NOR, 9294

Website

https://www.arcticzymes.com

ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Germany, Italy, France, and other countries.

ArcticZymes Technologies ASA Headlines

No Headlines